SCHEMBL3343833

SCHEMBL3343833

O=C(O)c1ccc2c(c1)[nH]c(=O)c1cc(Cl)c(Cl)n12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 3/20 0.44
GRIA2 P42262 3/20 0.44
GRIA3 P42263 3/20 0.44
GRIA4 P48058 3/20 0.44
GRIN2D O15399 2/20 0.44
GRIN3B O60391 2/20 0.44
GRIN1 Q05586 2/20 0.44
GRIN2A Q12879 2/20 0.44
GRIN2B Q13224 2/20 0.44
GRIN2C Q14957 2/20 0.44
GRIN3A Q8TCU5 2/20 0.44
PARP1 P09874 4/20 0.43
ALDH1A1 P00352 3/20 0.43
KMT2A Q03164 1/20 0.43
AURKA O14965 1/20 0.43
KDM4E B2RXH2 2/20 0.41
PDE9A O76083 1/20 0.40
CSNK2A1 P68400 3/20 0.40
TSHR P16473 1/20 0.40
CSNK2A2 P19784 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3337470 0.84 PARP1 (0.48) PARP1ALDH1A1KMT2AKDM4EPDE9A
SCHEMBL3339022 0.80 PARP1 (0.54) PARP1ALDH1A1KMT2AKDM4EMAPT
SCHEMBL3339450 0.80 PARP1 (0.43) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL28895087 0.77 PARP1 (0.46) PARP1ALDH1A1KMT2AAURKAKDM4E
SCHEMBL3336666 0.76 PARP1 (0.66) PARP1ALDH1A1KMT2A
SCHEMBL3341807 0.76 PLA2G10 (0.56) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL3784199 0.71 PARP1 (0.68) PARP1ALDH1A1KMT2AAURKAKDM4E
SCHEMBL21642461 0.71 GRIA2 (0.51) GRIA1GRIA2GRIA3GRIA4PARP1
SCHEMBL29203506 0.70 PARP1 (0.46) PARP1ALDH1A1KMT2AAURKAKDM4E
SCHEMBL3590864 0.70 PDE9A (0.49) GRIA1GRIA2GRIA3GRIA4PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152180-A1 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152180-A1 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) PARP1, PARP2, PARP4 GRIA1 3117/4885GRIA2 3547/4885GRIA3 3120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.